Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

Journal of Laboratory and Clinical Medicine

Volumn 135, Issue 4, 2000, Pages 353-359

  Ikeda, Yoshio ^a,b   Nakamura, Takamichi ^a,b,c   Takano, Hajime ^a,b   Kimura, Hideaki ^a,b   Obata, Jun Ei ^a,b   Takeda, Satoshi ^a,b   Hata, Akira ^a,b   Shido, Koichi ^a,b   Mochizuki, Seibu ^a,b   Yoshida, Yoji ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034048794     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.105617     Document Type: Article

References (39)

1. 1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. 2. Levy D. Left ventricular hypertrophy: epidemiological insights from the Framingham Heart Study. Drugs 1988;35 (suppl 5):1-5.
3. 3. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-8.
4. 4. Koven MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
5. 5. Dhlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertension 1992;5:95-110.
6. 6. Gohlke P, Linz W, Scholkens BA, Wiemer G, Unger T. Cardiac and ventricular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1996;28:397-402.
7. 7. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linz W, et al. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3-5-monophosphate. Hypertension 1993;22:682-7.
8. 8. MacFadyen RJ, Reid JL. Angiotensin receptor antagonists as a treatment for hypertension. J Hypertension 1994;12:1333-8.
9. 9. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637-52.
10. 10. Thiedemann KU, Holubarsch C, Medugorac I, Jacob R. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters. Basic Res Cardiol 1983;78:140-55.
11. 11. Jacob R. Different fractions in the normal and hypertrophied rat ventricular myocardium. Basic Res Cardiol 1976;71:608-23.
12. 12. Tanaka M, Fujiwara H, Onodera T, Wu D-J, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986;55:575-81.
13. 13. Douglas PS, Tallant B. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. J Am Coll Cardiol 1991;17:530-6.
14. 14. Weber KT, Brilla CG. Pathological hypertension and cardiac interstitium. Circulation 1991;83:1849-65.
15. 15. Olivetti G, Melissari M, Marchetti G, Anersa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Circ Res 1982;51:19-26.
16. 16. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke prone spontaneously hypertensive rat. Circ Res 1974; 35:143-53.
17. 17. Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneous hypertensive rats. Am J Physiol 1979;236:H409-16.
18. 18. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Circ Res 1991;69:107-15.
19. 19. Ito N, Isoyama S, Takahashi T, Takishima T. Coronary dilator reserve and morphological changes after relief of pressure-overload in rats. J Mol Cell Cardiol 1993;25:3-14.
20. 20. Hoh JY, Mcgrath A, Hale PT. Electrophoresis analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol 1977;10:1053-76.
21. 21. Martorana PA, Kettenbach B, Breipohl G, Linz W, Scholkens BA. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Parmacol 1990;182:395-6.
22. 22. Bao G, Gohlke P, Qadri F, Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 1992;20:74-9.
23. 23. Gohlke P, Bunning P, Unger T. Distribution and metabolism of angiotensin I and II in the blood vessel wall. Hypertension 1992;20:151-7.
24. 24. Campbell D, Kladis A, Valentijin AJ. Effect of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol 1995;26:233-40.
25. 25. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991;68:141-9.
26. 26. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res 1993;73: 413-23.
27. 27. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-74.
28. 28. Narayan S, Janicki JS, Shrecher SG, Pick R, Weber KT. Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats. Am J Hypertension 1989;2:675-82.
29. 29. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated cardiac fibrosis in the rat. Circ Res 1994;74:727-39.
30. 30. Childs TJ, Adams MA, Mak AS. Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins. Hypertension 1990;16:662-8.
31. 31. Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z, Ying W, et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994:89;2204-11.
32. 32. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiax phenotypic modulation and remodeling in vivo in rats. Hypertension 1995;25:1252-9.
33. 33. Kohlmann O Jr, Bresnahan M, Gavras H. Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normolensive rats. Hypertension 1984;6(suppl I):I-1-I-6.
34. 34. Sen S, Terazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertesive rats. Circ Res 1974;35:775-81.
35. 35. Waspe LE, Ordahl CP, Simpson PC. The cardiac-β-myosin heavy chain isogene is induced selectively in α-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest 1990;85:1206-14.
36. 36. Wangler RD, Peters KD, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982;51:10-8.
37. 37. Peters KG, Wangler RD, Tomanek RJ, Marcus ML. Effects of long-term cardiac hypertrophy on coronary vasodilator reserve in SHR rats. Am J Cardiol 1984;54:1342-8.
38. 38. Yamamoto J, Tsuchiya M, Saito M, Ikeda M. Cardiac contractile and coronary flow reserve in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1985;7:569-77.
39. 39. Clozel JP, Hefti F. Cilazapril improves the coronary vascular reserve in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1988;11:568-72.